These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 31457104

  • 1. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
    Lu L, Li Z, Li H, Li X, Vekilov PG, Karniadakis GE.
    Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
    Henry ER, Metaferia B, Li Q, Harper J, Best RB, Glass KE, Cellmer T, Dunkelberger EB, Conrey A, Thein SL, Bunn HF, Eaton WA.
    Blood; 2021 Sep 30; 138(13):1172-1181. PubMed ID: 34197597
    [Abstract] [Full Text] [Related]

  • 8. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
    Nwankwo HC, Idowu AA, Muhammad A, Waziri AD, Abubakar YS, Bashir M, Erukainure OL.
    Hum Exp Toxicol; 2021 Dec 30; 40(12_suppl):S108-S124. PubMed ID: 34151613
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC, Stallings M, Abraham A, Garbutt GJ.
    Biochim Biophys Acta; 1982 Jul 12; 705(1):76-81. PubMed ID: 7115734
    [Abstract] [Full Text] [Related]

  • 11. The molecular basis of antisickling agents.
    Franklin IM, Huehns ER.
    Trans R Soc Trop Med Hyg; 1980 Jul 12; 74(6):695-700. PubMed ID: 7210123
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting HbS Polymerization.
    Ferrone FA.
    Semin Hematol; 2018 Apr 12; 55(2):53-59. PubMed ID: 30616807
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
    Brittenham GM, Schechter AN, Noguchi CT.
    Blood; 1985 Jan 12; 65(1):183-9. PubMed ID: 3965046
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.